SAITTA, Carlo
 Distribuzione geografica
Continente #
EU - Europa 6.392
NA - Nord America 5.176
AS - Asia 2.886
SA - Sud America 840
AF - Africa 117
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.424
Nazione #
US - Stati Uniti d'America 5.073
RU - Federazione Russa 3.373
SG - Singapore 1.151
CN - Cina 868
BR - Brasile 722
IE - Irlanda 691
SE - Svezia 555
IT - Italia 545
HK - Hong Kong 291
DE - Germania 271
PL - Polonia 237
VN - Vietnam 178
FR - Francia 164
FI - Finlandia 146
GB - Regno Unito 127
IN - India 106
UA - Ucraina 100
BD - Bangladesh 56
CA - Canada 45
AR - Argentina 44
MX - Messico 39
BE - Belgio 37
NL - Olanda 35
ZA - Sudafrica 31
AT - Austria 28
TR - Turchia 28
ID - Indonesia 27
PK - Pakistan 23
CI - Costa d'Avorio 22
CZ - Repubblica Ceca 20
JP - Giappone 20
UZ - Uzbekistan 20
IQ - Iraq 19
MA - Marocco 18
EC - Ecuador 16
ES - Italia 16
CO - Colombia 14
AE - Emirati Arabi Uniti 13
PH - Filippine 11
VE - Venezuela 11
PY - Paraguay 10
SA - Arabia Saudita 10
JO - Giordania 9
KE - Kenya 9
MY - Malesia 9
EG - Egitto 8
DZ - Algeria 7
EE - Estonia 7
IL - Israele 7
NZ - Nuova Zelanda 7
TN - Tunisia 7
BO - Bolivia 6
CH - Svizzera 6
CL - Cile 6
UY - Uruguay 6
KG - Kirghizistan 5
NP - Nepal 5
OM - Oman 5
AL - Albania 4
AU - Australia 4
BY - Bielorussia 4
GH - Ghana 4
JM - Giamaica 4
LB - Libano 4
LV - Lettonia 4
PE - Perù 4
AZ - Azerbaigian 3
GE - Georgia 3
GT - Guatemala 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
RO - Romania 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CG - Congo 2
CR - Costa Rica 2
GD - Grenada 2
IR - Iran 2
KW - Kuwait 2
LT - Lituania 2
LY - Libia 2
NO - Norvegia 2
SN - Senegal 2
SV - El Salvador 2
BH - Bahrain 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KR - Corea 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 15.412
Città #
Ashburn 1.014
Moscow 973
Dallas 712
Dublin 691
Singapore 687
Chandler 502
Nyköping 329
San Jose 312
Hong Kong 290
Beijing 261
Messina 256
Jacksonville 229
Warsaw 229
The Dalles 158
Los Angeles 126
Ann Arbor 120
Dearborn 107
Lauterbourg 89
Munich 87
Princeton 83
Medford 78
New York 77
São Paulo 70
Cambridge 62
Des Moines 58
Boardman 57
Ho Chi Minh City 53
Houston 53
Buffalo 43
Helsinki 43
Tianjin 43
Council Bluffs 42
Turku 41
Orem 39
Bremen 38
Brussels 37
Frankfurt am Main 35
Jinan 34
Guangzhou 32
Santa Clara 32
Hanoi 30
Redondo Beach 30
Shenyang 27
Brasília 26
Brooklyn 25
Hyderabad 25
Pune 25
Chennai 23
Abidjan 22
Nuremberg 22
Rio de Janeiro 22
Rome 22
Wilmington 22
Belo Horizonte 21
Nanjing 21
Catania 20
Tokyo 19
Boston 18
Dong Ket 18
San Mateo 18
Shenzhen 18
Woodbridge 18
Amsterdam 17
Lancaster 17
Jakarta 16
London 16
Shanghai 16
Denver 15
Haikou 15
Johannesburg 15
Montreal 15
Vienna 15
Tashkent 14
Atlanta 13
Avola 13
Zhengzhou 13
Curitiba 12
Düsseldorf 12
Haiphong 12
Hangzhou 12
Hebei 12
Mexico City 12
Phoenix 12
Seattle 12
Chicago 11
Lahore 11
Porto Alegre 11
Stockholm 11
Manchester 10
Ningbo 10
Palermo 10
Poplar 10
Taizhou 10
Ankara 9
Baghdad 9
Brno 9
Campinas 9
Falls Church 9
Lappeenranta 9
New Delhi 9
Totale 9.177
Nome #
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 268
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 268
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 264
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 256
Atrial fibrillation in patients with cirrhosis 249
Biglycan expression, earlier vascular damage and pro-atherogenic profile improvement after smoke cessation in young people. 246
Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients 224
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 221
Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. 216
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 216
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 210
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 210
Does the margin width influence recurrence rate in liver surgery for hepatocellular carcinoma smaller than 5 cm? 209
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 209
A 1-year study on hydroxy-methylglutaryl coenzymea reductase gene expression and polymorphisms in hypercholesterolemic treated with statins. 208
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 207
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? 205
ANTIOXIDANT CAPACITY OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS (EPCS) AND CIGARETTE SMOKING 201
Ateromasia carotidea e livelli lipidici in soggetti affetti da DM2: risultati di una analisi retrospettiva 201
Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians 198
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 198
Erectile dysfunction in compensated liver cirrhosis 198
C-Reactive Protein (CRP) plasma levels, monocyte MCP-1 (Monocyte Chemoattractant Protein-1) and TF (Tissue Factor) mRNA in patients with primary arterial hypertension 196
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 193
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 192
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 190
Pulse wave velocity and augmentation index, but notintima-media thickness, are early indicators ofvascular damage in hypercholesterolemic children 186
Biglycan expression is increased in hypertensive subjects with normal or increased carotid intima-media wall thickness 184
Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number 181
Circulating progenitor cells and the elderly: a seven-year observational study. 180
Mitochondrial DNA is a target of HBV integration 180
Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness 176
Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress. 174
Anatomic variations: a rare variant of formation of the portal vein 173
Extracellular superoxide dismutase (EC-SOD) gene mutations screening in a sample of Mediterranean population 172
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 170
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 168
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 162
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 162
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 162
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 161
Capacità antiossidante delle cellule progenitrici endoteliali ed abitudine al fumo di sigaretta 161
879 CHOLANGIOPATHY AND HCC IN MDR3 DEFICIENCY 158
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 157
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 155
Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness. 155
Olmesartan and atorvastatin are effective in improving circulating progenitor cells profile in hypertensive subjects 153
Potenziali indicatori di longevità in una popolazione di anziani siciliani 148
Circulating progenitor cells and high density lipoprotein levels in elderly 148
Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment 148
Monofocal hepatocellular carcinoma: How much does size matter? 147
Obesity and liver cancer 147
Pattern of macrovascular invasion in hepatocellular carcinoma 143
The changing scenario of hepatocellular carcinoma in Italy: an update 143
CIRCULATING PROGENITOR CELLS AND HIGH DENSITY LIPOPROTEIN LEVELS IN ELDERLY 141
Fever and rhomboid target lesion in decompensated cirrhosis 138
XXI National Congress of the Italian Society for the Study of Arteriosclerosis (SISA) 21–24 November, Perugia, Italy 138
Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 138
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 135
Proposal of model for personalized early adapted cancer screening in people living with HIV: experience of "Gaetano Martino" Hospital University of Messina 133
Identification of extracellular superoxide dismutase, EC-SOD, mutations in a Sicilian population 132
Maternal and Neonatal Outcomes in Intrahepatic Cholestasis of Pregnancy 131
Smoke exposure and circulating progenitor cells: Evidence for modulation of antioxidant enzymes and cell count 130
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 127
Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians. 124
Tissue factor expression and activity are not increased in peripheral monocytes isolated from uncomplicated hypertensive patients 120
Left Ventricular Function in Hypertension: New Insight by Speckle Tracking Echocardiography. 118
Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness. 117
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 117
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy 113
Oxidative stress and flogosis: The role of endothelial progenitor cells in rheumathoid arthtritis 112
The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 1 112
Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR. 112
Arterial hypertension as a comorbidity of cirrhosis 111
PAF-AH gene polymorphisms and carotid atherosclerosis in sicilian hypercholesterolemic subjects 110
ACUTE KIDNEY INJURY IN CIRRHOTIC PATIENTS UNDERGOING CONTRAST-ENHANCED COMPUTED TOMOGRAPHY 109
Platelet-activating factor acetylhydrolase is not associated with carotid intima-media thickness in hypercholesterolemic Sicilian individuals 106
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 105
Vit d deficiency, depletion of circulating endothelial progenitor cells and impaired arterial stiffness in patients with ra 105
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia 101
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 96
Toll-like receptor 3 and interleukine 1b expression in circulating progenitor cells isolated from patients with rheumatoid arthritis 96
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma 95
The paraoxonase promoter polymorphism (-107)T > C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients 95
Virological profiles in hepatitis B virus / hepatitis C virus co-infected patients under interferon plus ribavirin therapy. 92
Occult hepatitis B virus infection: an update 91
Treatment of the Hepatitis B Virus and Hepatitis C Virus Combined Infection: Still a Challenge for the Hepatologist. 91
The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 2 90
Tissue Factor and Monocyte Chemoattractant Protein-1 expression in hypertensive subjects with normal or increased carotid intima-media thickness 88
Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with normal or increased carotid intima-media wall thickness. 88
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 87
Hepatocellular carcinoma: the point of view of the hepatitis B virus. 86
Occult hepatitis B virus and hepatocellular carcinoma. 86
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus hepatitis C virus-coinfected patients 84
OCCULT HBV IS HIGHLY PREVALENT IN PATIENTS WITH INTRAHEPATIC CHOLANGIOCARCINOMA AND IT IS DETECTED AS BOTH FREE EPISOMAL AND INTEGRATED DNA 82
Atezolizumab plus Bevacizumab after first-line multikinase inhibitors for advanced hepatocellular carcinoma: The concept of “drug class change” 78
Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 74
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 73
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors 73
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 72
Totale 15.059
Categoria #
all - tutte 48.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.036


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 0 0 0 0 0 36
2021/2022616 11 55 19 25 27 15 37 23 9 127 87 181
2022/20231.924 140 206 76 154 162 174 24 126 803 10 36 13
2023/2024484 37 79 27 40 32 109 3 22 2 49 21 63
2024/20252.519 30 70 75 154 162 128 95 452 584 159 245 365
2025/20268.295 423 623 619 493 643 1.658 947 1.066 1.091 407 186 139
Totale 15.692